[Federal Register: February 21, 2008 (Volume 73, Number 35)]
[Notices]               
[Page 9592]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr21fe08-95]                         

-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

 
Importer of Controlled Substances; Notice of Registration

    By Notice dated November 6, 2007 and published in the Federal 
Register on November 16, 2007 (72 FR 64678-64679), Fisher Clinical 
Services Inc., 7554 Schantz Road, Allentown, Pennsylvania 18106, made 
application by renewal to the Drug Enforcement Administration (DEA) to 
be registered as an importer of Noroxymorphone (9668), a basic class of 
controlled substance listed in schedule II.
    The company plans to import the listed controlled substance for 
analytical research and clinical trials.
    No comments or objections have been received. DEA has considered 
the factors in 21 U.S.C. 823(a) and 952(a) and determined that the 
registration of Fisher Clinical Services Inc. to import the basic class 
of controlled substance is consistent with the public interest and with 
United States obligations under international treaties, conventions, or 
protocols in effect on May 1, 1971, at this time. DEA has investigated 
Fisher Clinical Services Inc. to ensure that the company's registration 
is consistent with the public interest. The investigation has included 
inspection and testing of the company's physical security systems, 
verification of the company's compliance with state and local laws, and 
a review of the company's background and history. Therefore, pursuant 
to 21 U.S.C. 952(a) and 958(a), and in accordance with 21 CFR 1301.34, 
the above named company is granted registration as an importer of the 
basic class of controlled substance listed.

    Dated: February 12, 2008.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
 [FR Doc. E8-3171 Filed 2-20-08; 8:45 am]

BILLING CODE 4410-09-P